SEC Form 4 · accession 0001615219-16-000114
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michelle Stacy
Director
Period of report
Mar 5, 2016
Accepted (ET)
Mar 8, 2016 · 7:24 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.20 | Mar 5, 2016 | A | 20,000 | A | — | Mar 5, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The stock option will vest in 36 successive equal monthly installments measured from March 5, 2016.